Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 603,400 | 2,404,300 | 77,600 | 443,300 | 399,400 |
| Depreciation Amortization | 2,382,700 | 376,800 | 418,800 | 496,700 | 396,400 |
| Income taxes - deferred | -283,400 | -455,400 | 32,900 | -45,900 | 104,300 |
| Accounts receivable | -139,400 | -319,200 | -208,800 | -55,200 | -122,100 |
| Other Working Capital | -33,800 | -279,700 | -454,700 | -170,500 | -136,600 |
| Other Operating Activity | 473,400 | 358,100 | 560,200 | 447,200 | 444,900 |
| Operating Cash Flow | $3,002,900 | $2,084,900 | $426,000 | $1,115,600 | $1,086,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 119,100 | 180,500 | 680,700 | -561,100 | 46,200 |
| PPE Investments | -106,700 | -154,700 | -213,000 | -357,300 | -332,700 |
| Net Acquisitions | -2,111,900 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -16,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -16,100 | 2,800 | 100 | -1,100 |
| Investing Cash Flow | $-2,099,500 | $9,700 | $470,500 | $-918,300 | $-287,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 250,000 | N/A | N/A |
| Debt Repayment | -130,600 | -98,000 | -293,800 | -175,000 | -375,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 37,100 |
| Common Stock Repurchased | -510,800 | -416,000 | -85,000 | -463,600 | -430,600 |
| Other Financing Activity | 29,500 | -225,100 | 26,400 | 42,000 | -67,700 |
| Financing Cash Flow | $-611,900 | $-739,100 | $-102,400 | $-596,600 | $-836,200 |
| Exchange Rate Effect | 19,500 | 800 | -11,200 | 17,700 | -6,600 |
| Beginning Cash Position | 2,723,600 | 1,367,300 | 584,400 | 966,000 | 1,010,100 |
| End Cash Position | 3,034,600 | 2,723,600 | 1,367,300 | 584,400 | 966,000 |
| Net Cash Flow | $311,000 | $1,356,300 | $782,900 | $-381,600 | $-44,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,002,900 | 2,084,900 | 426,000 | 1,115,600 | 1,086,300 |
| Capital Expenditure | -106,700 | -154,700 | -213,000 | -357,300 | -332,700 |
| Free Cash Flow | 2,896,200 | 1,930,200 | 213,000 | 758,300 | 753,600 |